Selected Scientific Presentations
Since 2020
2022
International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
ISPOR Europe, Vienna / Austria, November 6-9, 2022:
Panel Session - Theme:
Towards a broader patients' perspective: The theory and practice of socioeconomic impact research.
(Concurrent Breakout Session 4)
Health economic evaluations alongside new clinical trial designs – Results of an international expert panel workshop.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S354.
The nature of quality appraisal in systematic literature reviews of health state utility values (HSUVS). A rapid evidence review.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S429.
Developing a conceptual framework for socioeconomic impact research in European cancer patients: A best-fit framework synthesis.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S430.
Costing for Socioeconomic Impact Analysis: Implications of Adopting a Patient's Perspective.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S67..
To what extent are long-term breast cancer survivors subjected to financial burden in Germany? Results from a patient survey-based study.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S397.
Challenges of health economic evaluations alongside innovative clinical trial designs in precision oncology – Results of a literature review.
(Poster Presentation)
Value in Health, 2022; 25(12) Supplement, S154.
World Cancer Congress (WCC) 2022
Geneva, Switzerland, October 18-20, 2022:
"Cancer-related HTAs in England and Germany: A comparison of outcomes and evaluation criteria"
(Presentation available on request)
"Financial impact on cancer patients in Germany during the COVID-19 pandemic"
(Presentation available on request)
Eingeladener Beitrag zur Sitzung des Ausschuss Klinische Forschung des Bundesverbands der Pharmazeutischen Industrie (BPI)
Berlin, Germany, September 13, 2022:
"The Cost of New Drug Development"
(Presentation available on request)
EbM Congress 2022
Online-Pre-Conference, Germany, March 18, 2022:
"Auswirkungen der Corona-Pandemie für Krebsbetroffene und ihre Versorgung: Ergebnisse einer Befragungsstudie"
(Online Poster Presentation available on request)
2021
20. Deutscher Kongress für Versorgungsforschung (DKVF)
Berlin / Germany, October 06-08, 2021:
Impact of the corona pandemic on cancer patients: Results from a German cross-sectional pilot study.
(Poster Presentation available on request)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Hybrid Event, Berlin / Germany, October 01-04, 2021:
Online survey of cancer patients on changes in care and on psycho-social burden during the pandemic.
(Poster Presentation available on request)
2020
International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Virtual ISPOR Europe, November 16 – November 19, 2020:
Social Cost Value Analysis: Do we need an alternative health economic evaluation paradigm?
(Online Panel Session)
Conference proceedings from Virtual ISPOR Europe 2020.
The acquisition cost and efficiency of CAR T-cell therapies: can they be improved by decentralized manufacturing?
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S460.
The role of the budget impact: A multivariate analysis of health technology assessment (HTA) outcomes by GBA/IQWiG in Germany and NICE in England.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S530.
How much does it cost to research & develop a new drug? A systematic review and evaluation of 40 years of literature.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S756.
A systematic review of the socioeconomic impact of cancer on patients and families: Are differences among countries being effectively captured and addressed?
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S478.
Modeling the duration of protective effects and resource use of colonoscopy screening by a discrete event simulation model calibrated with German screening registry data.
(Online Research Poster Presentation)
Value in Health (2020), 23(S2): S456-457.
German, Austrian and Swiss Associations of Hematology and Medical Oncology (DGHO)
October 09 – October 11, 2020:
Direct and indirect cost of malignant cutaneous melanoma in European countries – Results of a literature review.
(Abstract Video Presentation)
DGHO Annual Meeting 2020.
European Society for Medical Oncology (ESMO)
ESMO Virtual Congress, September 19 – September 21, 2020:
Can we reduce the acquisition cost of CAR T-cell therapies?
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S966.
Health technology assessment (HTA) in England, France and Germany: What do we know about variations in cancer-related HTA outcomes?
(Online Presentation)
Annals of Oncology (2020), 31(S4): S1197.
How much does it cost to research and develop a new medicine? A systematic review and evaluation of 40 years of literature.
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S962.
Modelling the long-term effectiveness of colonoscopy screening by a discrete event simulation model calibrated with German screening registry data.
(Online Research Poster Presentation)
Annals of Oncology (2020), 31(S4): S457-458.
International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Virtual ISPOR, May 18 – May 20, 2020:
´Advancing evidence to action´: A comparison of health technology assessment (HTA) outcomes in England, France and Germany.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S70.
Income loss after a cancer diagnosis in Germany: an analysis based upon the socio-economic panel survey.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S76.
The social and socioeconomic impact ofcancer on patients and their families: A systematic review.
(Online Research Poster Presentation)
Value in Health (2020), 23(S1): S78.